Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.
The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.
The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.
Publications found:
25,296
Sort by:
Global Fill Finish Manufacturing Market Size Study and Forecast by Product Type (Consumables, Equipment), Drug Type (Biologics, Small Molecules), End-user (Pharmaceutical Companies, Biopharmaceutical Companies), and Regional Forecasts 2026-2035
US$ 3,750.00
Fill finish manufacturing represents the final and highly critical stage of pharmaceutical production, involving the aseptic filling of drug formulations into vials, syringes, cartridges, or other pri...
April 2026
285 pages
Global Pharmaceutical Excipients Market Size Study and Forecast by Functionality (Binders and Adhesives, Disintegrants, Coating Material, Coloring Agents, Solubilizers, Flavors, Sweetening Agents, Diluents, Lubricants, Buffers, Emulsifying Agents, Preservatives, Antioxidants, Sorbents, Solvents, Emollients, Glidents, Chelating Agents, Antifoaming Agents, and Others), by Dosage Form (Solid, Semi-Solid, and Liquid), by Route of Administration (Oral Excipients, Topical Excipients, Parenteral Excipients, and Other Excipients), by End User (Pharmaceutical and Biopharmaceutical Companies, Contract Formulators, Research Organization and Academics, and Others), by Distribution Channel (Direct Tender, Retail Sales, and Others), and Regional Forecasts 2026-2035
US$ 3,750.00
Pharmaceutical excipients are inactive substances formulated alongside active pharmaceutical ingredients (APIs) to support the manufacturing process, enhance drug stability, improve bioavailability, a...
April 2026
285 pages
Global Pharmacy Automation Equipment Market Size Study and Forecast by Product Type (Automated Medication Dispensing Systems, Automated Packaging and Labeling Systems, Automated Storage and Retrieval Systems, Automated Medication Compounding Systems, and Others), by Application (Inpatient Pharmacies, Outpatient Pharmacies, Retail Pharmacies, and Others), by End-User (Hospitals, Retail Pharmacies, Long-Term Care Facilities, and Others), and Regional Forecasts 2026-2035
US$ 3,750.00
The global pharmacy automation equipment market comprises advanced systems and technologies designed to streamline medication dispensing, storage, packaging, and compounding processes within pharmacy...
April 2026
285 pages
Emerging Drugs: Global Markets
US$ 2,950.00
The report analyzes the trends in the global emerging drugs market. It includes global revenue ($ billions) for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The...
April 2026
93 pages
Peptide Therapeutics Market - 2026-2033
US$ 3,400.00
Peptide Therapeutics Marketis is growing with a CAGR of 7.80% during the forecast period 2026-2035. The Peptide Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysi...
April 2026
46 pages
Pharmaceutical Analytical Testing Outsourcing Market Size by Type (Active Pharmaceutical Ingredients (API), Additives, Finished Products), Service (Bioanalytical Testing, Method Development and Validation, Stability Testing, and Others), End User (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Research Organizations), and Region 2026-2034
US$ 2,999.00
The global pharmaceutical analytical testing outsourcing market size reached USD 9.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 16.5 Billion by 2034, exhibiting a gr...
April 2026
144 pages
Gaucher Disease Market by Type (Gaucher Disease Type 1, Gaucher Disease Type 2, Gaucher Disease Type 3, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2026-2034
US$ 2,999.00
The global gaucher disease market size reached USD 1.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.1 Billion by 2034, exhibiting a growth rate (CAGR) of 5.76% durin...
April 2026
148 pages
Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2026-2034
US$ 2,999.00
The global infantile spasms therapeutics market size reached USD 3.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.3 Billion by 2034, exhibiting a growth rate (CAGR)...
April 2026
136 pages
Acquired Orphan Blood Diseases Therapeutics Market Report by Therapy (Recombinant Factor, Immunoglobulin Infusion Therapy, Activated Prothrombin Complex Concentrate, Thrombopoietin Receptor Agonists, and Others), Disease Indication (Acquired Agranulocytosis, Acquired Hemophilia, Acquired Von Willebrand Syndrome, Paroxysmal Nocturnal Hemoglobinuria (PNH), Myelodysplastic Syndrome, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others), and Region 2026-2034
US$ 2,999.00
The global acquired orphan blood diseases therapeutics market size reached USD 10.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 18.7 Billion by 2034, exhibiting a gro...
April 2026
147 pages
Oral Antibiotics Market Report by Class (Beta Lactam and Beta Lactamase Inhibitors, Quinolone, Macrolide, and Others), Application (Community-acquired Respiratory Tract Infections (CARTIs), Urinary Tract Infections (UTIs), Dental and Others), Drug Origin (Natural, Semisynthetic, Synthetic), Spectrum of Activity (Broad-spectrum Antibiotic, Narrow Spectrum Antibiotic), Drug Type (Branded, Generics), and Region 2026-2034
US$ 2,999.00
The global oral antibiotics market size reached USD 21,749.4 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 28,759.4 Million by 2034, exhibiting a growth rate (CAGR) of...
April 2026
142 pages
Opioids Market Report by Product Type (Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone), Application (Pain Management, Cough Treatment, Diarrhea Treatment, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Stores, and Others), and Region 2026-2034
US$ 2,999.00
The global opioids market size reached USD 23.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 29.2 Billion by 2034, exhibiting a growth rate (CAGR) of 2.55% during 2026...
April 2026
146 pages
Peptide Therapeutics Market Size, Share, Trends and Forecast by Type, Type of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region, 2026-2034
US$ 2,999.00
The global peptide therapeutics market size was valued at USD 49.7 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 92.6 Billion by 2034, exhibiting a CAGR of 6.95% duri...
April 2026
146 pages
Binder Excipients Market Report by Product Type (Cellulosics, Lactose, Polyols, Povidones, Starch and Polysaccharides, Co-Processed Compressible Excipients, and Others), Application (Tablets and Capsules, Solution Based), and Region 2026-2034
US$ 2,999.00
The global binder excipients market size reached USD 1.6 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.3 Billion by 2034, exhibiting a growth rate (CAGR) of 3.77% dur...
April 2026
135 pages
Human Chorionic Gonadotropin (HCG) Market Report by Technology (Natural Source Extraction, Recombinant Technology), Therapeutic Area (Female Infertility Treatment, Male Hypogonadism, Oligospermic Treatment, and Others), End User (Fertility Clinics, Research Institutions, and Others), and Region 2026-2034
US$ 2,999.00
The global human chorionic gonadotropin (HCG) market size reached USD 1,103.8 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,905.9 Million by 2034, exhibiting a growth...
April 2026
142 pages
Travel Vaccines Market Report by Composition (Mono Vaccines, Combination Vaccines), Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and Region 2026-2034
US$ 2,999.00
The global travel vaccines market size reached USD 4.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 10.5 Billion by 2034, exhibiting a growth rate (CAGR) of 8.63% duri...
April 2026
140 pages
Clinical Nutrition Market Report by Product (Infant Nutrition, Parental Nutrition, Enteral Nutrition), Route of Administration (Oral, Enteral, Parenteral), Application (Cancer, Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others), End User (Pediatric, Adults, Geriatric), and Region 2026-2034
US$ 2,999.00
The global clinical nutrition market size reached USD 59.8 Billion in 2025. Looking forward, the market is expected to reach USD 111.4 Billion by 2034, exhibiting a growth rate (CAGR) of 6.94% during...
April 2026
135 pages
Contrast Media Market Report by Type (Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, Barium-based Contrast Media), Modality (X-ray/Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound), Application (Radiology, Interventional Radiology, Interventional Cardiology), Route of Administration (Intravenous/Intrarterial, Oral Route, Rectal Route, and Others), End User (Hospital, Clinics and Ambulatory Surgery Centers, Diagnostic Imaging Centers), and Region 2026-2034
US$ 2,999.00
The global contrast media market size reached USD 5.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.41% during...
April 2026
144 pages
Fabry Disease Market Report by Type (Type 1, Type 2, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2026-2034
US$ 2,999.00
The global fabry disease market size reached USD 2.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2034, exhibiting a growth rate (CAGR) of 5.78% during...
April 2026
142 pages
Immunotherapy Drugs Market Report by Drug Type (Monoclonal Antibodies, Vaccines, Interferons Alpha and Beta, Interleukins), Therapy Area (Cancer, Autoimmune and Inflammatory Diseases, Infectious Diseases, and Others), End User (Hospitals, Clinics, and Others), and Region 2026-2034
US$ 2,999.00
The global immunotherapy drugs market size reached USD 246.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 464.3 Billion by 2034, exhibiting a growth rate (CAGR) of 7.0...
April 2026
138 pages
Inventory Tank Gauging System Market Report by Type (Point Level Instruments, Continuous Level Instruments), Technology (Electronic ITG, Mechanical ITG), Application (Aviation, Defense, Oil and Gas, and Others), and Region 2026-2034
US$ 2,999.00
The global inventory tank gauging system market size reached USD 701.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 898.9 Million by 2034, exhibiting a growth rate (CA...
April 2026
142 pages
Magnetite Nanoparticles Market Report by Type (Iron Based, Cobalt Based), Physical Form (Nanopowder, Solution, Dispersion), Application (Bio-medical, Electronics, Wastewater Treatment, Energy, and Others), and Region 2026-2034
US$ 2,999.00
The global magnetite nanoparticles market size reached USD 98.0 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 213.2 Million by 2034, exhibiting a growth rate (CAGR) of...
April 2026
138 pages
North America Analgesics Market Size, Share, Trends and Forecast by Type, Drug Class, Route of Administration, Pain Type, Application, and Country, 2026-2034
US$ 2,999.00
The North America analgesics market size was valued at USD 25.6 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 33.1 Billion by 2034, exhibiting a CAGR of 2.78% from 20...
April 2026
137 pages
North America Hormone Replacement Therapy Market Report by Product (Estrogen Replacement Therapy, Human Growth Hormone Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy, and Others), Route of Administration (Oral, Parenteral, Transdermal), Type of Disease (Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Others), and Country 2026-2034
US$ 2,999.00
The North America hormone replacement therapy market size reached USD 4.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 7.2 Billion by 2034, exhibiting a growth rate (C...
April 2026
137 pages
Onychomycosis Treatment Market Report by Disease Type (Distal Subungual Onychomycosis, Proximal Subungual Onychomycosis, White Superficial Onychomycosis, Candidal Onychomycosis, and Others), Treatment Type (Laser Therapy, Photodynamic Therapy, Drug Treatment), Drug Class (Allylamine, Azole, Griseofulvin, and Others), Distribution Channel (Hospitals and Clinics, Online Stores, Retail Pharmacies, and Others), and Region 2026-2034
US$ 2,999.00
The global onychomycosis treatment market size reached USD 3.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 5.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.1...
April 2026
150 pages
Pediatric Vaccines Market Report by Type (Multivalent, Monovalent), Technology (Conjugate, Live Attenuated, Inactivated, Subunit, Toxoid, and Others), Application (Infectious Disease, Cancer, Allergy, and Others), and Region 2026-2034
US$ 2,999.00
The global pediatric vaccines market size reached USD 42.4 Billion in 2025 . Looking forward, IMARC Group expects the market to reach USD 75.1 Billion by 2034 , exhibiting a growth rate (CAGR) of 6.35...
April 2026
143 pages
Testosterone Replacement Therapy Market Report by Product Type (Oral implants, Injections, Patches, Creams/Gels, Gums/Buccal Adhesives, and Others), Active Ingredients (Testosterone, Methyl Testosterone, Testosterone Cypionate, Testosterone Undecanoate, Testosterone Enanthate), End User (Hospitals, Homecare, Specialty Clinics, and Others), and Region 2026-2034
US$ 2,999.00
The global testosterone replacement therapy market size reached USD 2.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.8 Billion by 2034, exhibiting a growth rate (CAG...
April 2026
145 pages
Therapeutic Vaccines Market Report by Type (Antigen Vaccines, Dendritic Cell Vaccine, DNA Vaccine, Tumor Cell Vaccines), Disease Type (Autoimmune Disease Vaccines, Addiction Vaccines, Neurological Disease Vaccine, Infectious Disease Vaccine, and Others), Technology (Autologous Vaccines, Allogeneic Vaccine), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2026-2034
US$ 2,999.00
The global therapeutic vaccines market size reached USD 37.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 78.5 Billion by 2034, exhibiting a growth rate (CAGR) of 8.32...
April 2026
137 pages
Anti-infectives Market Report by Type (Antibacterial, Antifungal, Antiviral), Route of Administration (Topical, Oral, Intravenous (IV), and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Speciality Pharmacies, Online Stores, and Others), and Region 2026-2034
US$ 2,999.00
The global anti-infectives market size reached USD 142.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 182.9 Billion by 2034, exhibiting a growth rate (CAGR) of 2.70% d...
April 2026
145 pages
Cholera Vaccines Market Report by Vaccine Type (Whole Cell V. Cholerae O1 with Recombinant B-Subunit, Killed Oral O1 and O139), Product (Dukoral, Shanchol, Vaxchora, Euvichol and Euvichol-Plus, and Others), End User (Hospitals and Clinics, Research and Academic Laboratories, and Others), and Region 2026-2034
US$ 2,999.00
The global cholera vaccines market size reached USD 6.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 14.3 Million by 2034, exhibiting a growth rate (CAGR) of 8.85% dur...
April 2026
138 pages
Electronic Data Capture (EDC) Systems Market Report by Delivery Mode (On-premise, Web & Cloud-based), Component (Software, Services), Development Phase (Phase I, Phase II, Phase III, Phase IV), End User (Hospitals/Healthcare Providers, CROs, Pharmaceutical and Biotechnology Firms, Medical Device Firms, and Others), and Region 2026-2034
US$ 2,999.00
The global electronic data capture (EDC) systems market size reached USD 1.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.5 Billion by 2034, exhibiting a growth rate...
April 2026
150 pages
Hyperphosphatemia Drugs Market Report by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2026-2034
US$ 2,999.00
The global hyperphosphatemia drugs market size reached USD 4.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.4 Billion by 2034, exhibiting a growth rate (CAGR) of 6.4...
April 2026
140 pages
Influenza Diagnostics Market Report by Product (Test Kit and Reagents, Instruments, and Others), Test Type (Molecular Diagnostic Tests, Traditional Diagnostic Tests), Type of Flu (Type A Flu, Type B Flu, Type C Flu), End User (Hospitals, Diagnostic Laboratories, and Others), and Region ?2026-2034?
US$ 2,999.00
The global influenza diagnostics market size reached USD 1,066.5 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 1,668.0 Million by 2034, exhibiting a growth rate (CAGR)...
April 2026
142 pages
IVF Devices and Consumables Market Report by Product (Instruments, Accessories and Disposables, Reagents and Media), Technology (Fresh Embryo IVF, Frozen Embryo IVF, Donor Egg IVF), End User (Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes), and Region 2026-2034
US$ 2,999.00
The global IVF devices and consumables market size reached USD 3.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 9.3 Billion by 2034, exhibiting a growth rate (CAGR) of...
April 2026
138 pages
Neutropenia Treatment Market Report by Treatment (Colony-Stimulating Factors, Antibiotics, Antifungals, Antivirals), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2026-2034
US$ 2,999.00
The global neutropenia treatment market size reached USD 16.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.4 Billion by 2034, exhibiting a growth rate (CAGR) of 4.5...
April 2026
141 pages
Non-Alcoholic Steatohepatitis (NASH) Market by Drug Type (Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib, Cenicriviroc, and Others), Disease Cause (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity), Sales Channel (Hospital Pharmacy, Online Providers, Retail Pharmacy), End User (Hospitals, Clinics, Homecare Settings), and Region 2026-2034
US$ 2,999.00
The global non-alcoholic steatohepatitis (NASH) market size reached USD 2.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 14.9 Billion by 2034, exhibiting a growth rate...
April 2026
141 pages
Peptic Ulcer Drugs Market Size by Product Type (Proton Pump Inhibitors, Potassium-Competitive Acid Blocker (P-CAB), Antacids, H2-Antagonists, Antibiotics, Ulcer protective), Ulcer Type (Gastric Ulcer, Duodenal Ulcer, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2026-2034
US$ 2,999.00
The global peptic ulcer drugs market size reached USD 5.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.3 Billion by 2034, exhibiting a growth rate (CAGR) of 2.41% du...
April 2026
143 pages
Anti-Tuberculosis Therapeutics Market Report by Disease Type (Active TB, Latent TB, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2026-2034
US$ 2,999.00
The global anti-tuberculosis therapeutics market size reached USD 1,615.1 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 2,615.3 Million by 2034, exhibiting a growth rat...
April 2026
143 pages
Antifibrinolytic Drugs Market Report by Indication (Gynecology, Hereditary Angioedema, Fibrinolytic Response Testing, Surgeries, and Others), Form (Oral, Injectable), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Trauma Centers, and Others), and Region 2026-2034
US$ 2,999.00
The global antifibrinolytic drugs market size reached USD 18.3 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 25.1 Billion by 2034, exhibiting a growth rate (CAGR) of 3....
April 2026
135 pages
